证券记录 · 已归档季度
PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
13被追踪持有人
—Δ持有人
6.89M持有股份
$197.00M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +2 | 30.85M | $781.81M | +7 | −4 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 2.07M | — | $59.11M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.09M | — | $31.17M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.09M | — | $31.17M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Marshall Wace ✦ | 971.14K | — | $27.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 971.14K | — | $27.78M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 806.10K | — | $23.06M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 806.10K | — | $23.06M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 806.10K | — | $23.06M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 806.10K | — | $23.06M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 487.13K | — | $13.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 487.13K | — | $13.94M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 487.13K | — | $13.94M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 487.13K | — | $13.94M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 487.13K | — | $13.94M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 480.43K | — | $13.75M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 480.43K | — | $13.75M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 300.06K | — | $8.58M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 249.14K | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 249.14K | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Norges Bank ✦ (被动) | 210.06K | — | $6.01M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 76.02K | — | $2.18M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 67.61K | — | $1.93M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 67.61K | — | $1.93M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 53.41K | — | $1.53M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 28.93K | — | $827,630 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3 持有人, 13.02M 股份, $12.57M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据